Advertisement
Home Tags Drug Approvals

Tag: Drug Approvals

The chemotherapy drug Yondelis (trabectedin) has been approved by the U.S. Food and Drug Administration to treat certain advanced or unresectable soft-tissue sarcomas.

FDA Approves Yondelis for Soft-Tissue Sarcoma

Drug sanctioned for liposarcoma or leiomyosarcoma
Coagadex (coagulation Factor X) has been approved by the U.S. Food and Drug Administration as the first coagulation factor replacement therapy for people with a rare blood disorder known as hereditary Factor X deficiency.

FDA Approves Coagadex for Rare Clotting Disorder

First coagulation therapy sanctioned for Factor X deficiency
Praxbind (idarucizumab) has been approved for use in patients who are taking the anticoagulant Pradaxa (dabigatran) when there is an urgent need to reverse Pradaxa's anticoagulant effects

FDA Approves Praxbind to Reverse Pradaxa’s Effect

Praxbind cleared for emergency use with Pradaxa when bleeding can't be controlled
The U.S. Food and Drug Administration on Monday expanded its approval for the Optune device to include newly diagnosed glioblastoma multiforme.

FDA Approves Optune Device for Newly Diagnosed Glioblastoma

Newly sanctioned to treat just-diagnosed patients, in combination with temozolomide
Aristada (aripiprazole lauroxil) extended-release injection has been approved by the U.S. Food and Drug Administration to treat schizophrenia

FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia

Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of non-small-cell lung cancer with tumors that express the PD-L1 protein. Keytruda is approved for use with the PD-L1 IHC 22C3 pharmDx test

FDA Approves Keytruda for Advanced NSCLC

Approved for use with PD-L1 IHC 22C3 pharmDx test
The combination pill Lonsurf (trifluridine and tipiracil) has been approved by the U.S. Food and Drug Administration to treat metastatic colorectal cancer in patients who aren't responding to other treatments

FDA Approves Lonsurf for Metastatic Colorectal Cancer

For patients with metastatic CRC previously treated with chemotherapy, biological therapy
A new antipsychotic drug to treat schizophrenia and bipolar disorder in adults has been approved by the U.S. Food and Drug Administration. The drug

FDA Approves New Drug for Schizophrenia, Bipolar Disorder

Vraylar is an atypical antipsychotic taken once a day
Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

For prevention of the delayed phase of nausea, vomiting caused by chemotherapy
Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration

FDA Approves Repatha for Certain Patients With High Cholesterol

Approved for patients unable to get LDL cholesterol under control with current treatment options